ArticleImmunology and cell biology2025

Serum proteomic and metabolomic analyses from patients with IBD identify biological pathways associated with treatment success with anti-integrin therapy.

John D Rioux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.